AEBP1 and metabolic dysfunction-associated steatohepatitis: In summary, we found that AEBP1 expression was increased in human liver biopsies from patients with NASH fibrosis, in activated human stellate cells, and in human liver cells treated with glucose, fructose, and palmitate.